Cargando…
Treatment of IgG4-related disease-associated hypertrophic pachymeningitis with intrathecal rituximab: a case report
IgG4-related disease-associated hypertrophic pachymeningitis (IgG4RD-HP) is a fibroinflammatory autoimmune disorder in which diagnosis is difficult without biopsy. Guidance on management of disease refractory to glucocorticoids and intravenous rituximab is limited. We present the case of a 68-year-o...
Autores principales: | Balaban, Denis T., Hutto, Spencer K., Panzarini, Bruno P., O'Shea, Aileen, Varma, Aditi, Jones, Pamela S., Chwalisz, Bart K., Stone, John H., Venna, Nagagopal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244657/ https://www.ncbi.nlm.nih.gov/pubmed/37292126 http://dx.doi.org/10.3389/fneur.2023.1189778 |
Ejemplares similares
-
Nodular Pachymeningitis Associated With Relapsing Polychondritis and Crohn Disease Responsive to Adalimumab and Prednisone
por: Hutto, Spencer K., et al.
Publicado: (2021) -
Response to Letter to the Editor: Spinomedullary Weston Hurst Syndrome After COVID-19 and Influenza Co-Infection
por: Hutto, Spencer K., et al.
Publicado: (2022) -
Rituximab Treatment for Idiopathic Hypertrophic Pachymeningitis
por: Jang, Yoonhyuk, et al.
Publicado: (2017) -
Refractory IgG4-related intracranial hypertrophic pachymeningitis responded to rituximab
por: Liao, Bing, et al.
Publicado: (2014) -
IgG4-Related Disease and Hypertrophic Pachymeningitis
por: Wallace, Zachary S., et al.
Publicado: (2013)